Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-26Clinical Trial Update: Irradiated Donor Lymphocyte Infusion Plus High-dose IL-2 [Phase 2]
Phase 2 study of irradiated donor lymphocyte infusion plus high-dose interleukin-2 for metastatic melanoma and renal cell carcinoma was term…
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: Sensitivity/Specificity Study of Non-invasive Imaging for Melanoma Diagnosis
A completed clinical trial evaluating the sensitivity and specificity of a non-invasive imaging method for diagnosing melanoma.
-
CLINICAL_TRIALS trial_result · 2016-04-25Clinical Trial Update: Effect of Biological Therapy on Biomarkers in Patients With Untreated Hepatitis C, Metastatic Melanoma, or Crohn Disease
Clinical trial evaluating a biological therapy's effect on biomarkers in untreated Hepatitis C, metastatic melanoma, and Crohn's disease was…
-
CLINICAL_TRIALS trial_result · 2016-04-22Clinical Trial Update: Safety and Pharmacodynamic Study of a New Formulation, AGI - 101H Vaccine in the Treatment of Advanced Melanoma [Phase 1, Phase 2]
A safety and pharmacodynamic study of the AGI-101H vaccine for advanced melanoma has been terminated after Phase 1 and Phase 2 trials.
-
CLINICAL_TRIALS withdrawal · 2016-04-21Clinical Trial Update: Combo of Abraxane, TMZ, Bevacizumab in Metastatic Melanoma With Brain Metastases [Phase 1, Phase 2]
The University of Arizona-sponsored Phase 1/2 trial of Abraxane plus temozolomide and bevacizumab for metastatic melanoma with brain metasta…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-04-18Clinical Trial Update: Phase I-II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation and Pharmacokinetics of PD-0332991 in Patients Suffering Metastatic Melanoma [Phase 1, Phase 2]
Phase I–II study evaluating tumor molecular pharmacodynamics and pharmacokinetics of palbociclib (PD-0332991) in patients with metastatic me…
-
CLINICAL_TRIALS trial_result · 2016-04-15Clinical Trial Update: A Phase 1 Study of Nivolumab (BMS-936558) in Subjects With Advanced or Recurrent Malignancies [Phase 1]
Phase 1 study of nivolumab (BMS-936558) in advanced or recurrent malignancies completed; results posted.
-
CLINICAL_TRIALS trial_result · 2016-04-12Clinical Trial Update: A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients [Phase 1]
This document describes a Phase 1 tolerability and pharmacokinetics study of SHR6390 in patients with advanced melanoma. The sponsor is Jian…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: Study to Assess Safety and Immune Response of Stage IIB-IV Resected Melanoma After Treatment With MAGE-A3 ASCI [EARLY_Phase 1]
Update on an early-phase trial evaluating the safety and immune response of MAGE-A3 ASCI in patients with resected stage IIB-IV melanoma; th…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Vaccine Therapy Plus Interleukin-2 With or Without Interferon Alfa-2b in Treating Patients With Stage III Melanoma [Phase 2]
Phase 2 trial update of a vaccine therapy plus interleukin-2, with or without interferon alfa-2b, in patients with Stage III melanoma; the s…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: Impact of Excision Margins on Survival and Recurrence Rate in Patients With Thick Melanoma (>2mm)
This clinical trial update reports on how different excision margins affect survival and recurrence in patients with thick melanoma (>2 mm).
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Comparison of In-House Methods and Cobas BRAF V600 Mutation Assay in Melanoma Tumor Samples
A completed clinical trial compared in-house methods against the Cobas BRAF V600 mutation assay for detecting BRAF V600 mutations in melanom…
-
CLINICAL_TRIALS trial_result · 2016-03-17Clinical Trial Update: Bevacizumab With or Without Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma [Phase 2]
Phase 2 trial assessing bevacizumab with or without interferon alfa-2b in patients with metastatic melanoma has completed and results were p…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: An Open-Label, 2-Cohort, Multicenter, Study of Lenvatinib in Previously Treated Subjects With Unresectable Stage III or Stage IV Melanoma [Phase 2]
Phase 2 open-label trial of lenvatinib in previously treated patients with unresectable stage III or stage IV melanoma completed; results po…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Post-Approval Study of MelaFind
Post-approval study of the melanoma diagnostic device MelaFind has been terminated (status: TERMINATED).
-
CLINICAL_TRIALS research · 2016-03-09Clinical Trial Update: Telephone-Based Educational Intervention in Improving Communication Between Patients With Stage 0-III Cancer and Their Children [NA]
Clinical trial status update noting the completion of a telephone-based educational intervention study designed to improve communication bet…
-
CLINICAL_TRIALS trial_result · 2016-03-02Clinical Trial Update: FR901228 in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma [Phase 2]
Phase 2 clinical trial update for FR901228 in unresectable stage III or stage IV malignant melanoma (melanoma) has been terminated with resu…
-
CLINICAL_TRIALS research · 2016-03-01Clinical Trial Update: Expanded Access Protocol of Talimogene Laherparepvec for Subjects With Unresected, Stage lllB to IVM1c Melanoma
Expanded Access Protocol update for talimogene laherparepvec in unresected stage IIIB to IV M1c melanoma indicates the protocol is no longer…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Study of Nivolumab (BMS-936558) Compared With Dacarbazine in Untreated, Unresectable, or Metastatic Melanoma [Phase 3]
Phase 3 trial comparing nivolumab to dacarbazine in untreated unresectable or metastatic melanoma completed with posted results.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Ph 1 Trial of ADI-PEG 20 Plus Cisplatin in Patients With Metastatic Melanoma [Phase 1]
Phase 1 trial evaluating ADI-PEG 20 plus cisplatin in metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Metastatic Melanoma of the Eye That Cannot Be Removed By Surgery [Phase 2]
Phase 2 clinical trial evaluating paclitaxel albumin-stabilized nanoparticle formulation (nab-paclitaxel) for metastatic intraocular melanom…
-
FDA approval · 2016-02-02FDA Approved: ISOSULFAN BLUE — Original Application (Eugia US LLC)
FDA approved the original application for Isosulfan Blue by Eugia US LLC, authorizing its use as a lymphatic mapping dye for sentinel lymph …
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Dacarbazine and Carmustine in Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating dacarbazine and carmustine in metastatic melanoma was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Phase II Trial of Neoadjuvant Temozolomide in Melanoma Patients With Palpable Stage III or IV Disease Undergoing Complete Surgical Resection [Phase 2]
Phase II trial evaluating neoadjuvant temozolomide in patients with palpable Stage III/IV melanoma undergoing complete surgical resection; r…
-
CLINICAL_TRIALS research · 2016-02-01Clinical Trial Update: Concurrent Ipilimumab and Stereotactic Ablative Radiation Therapy (SART) for Oligometastatic But Unresectable Melanoma [Phase 2]
A Phase 2 trial update discusses concurrent ipilimumab with stereotactic ablative radiation therapy for oligometastatic, unresectable melano…